Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

NCT05172193 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated

Sponsor

PT. Kimia Farma (Persero) Tbk